A series of berberine azoles was synthesized and characterized by NMR, IR, MS and HRMS spectroscopy. All the newly prepared compounds were screened for their antimicrobial activities. Bioactivity assays manifested that most of the berberine azoles exhibited good antimicrobial activities. Especially compound 7a displayed remarkable anti-Proteus vulgaris and anti-Candida mycoderma efficacies, which were comparable to or even better than for the reference drugs. The binding behavior of compound 7a to human serum albumin (HSA) revealed that hydrophobic interactions and hydrogen bonds play important roles in the association of compound 7a with HSA. Molecular docking experiments showed that compound 7a has moderate affinity to HSA, and the theoretical calculations were in accordance with the experimental results.
合成并表征了一系列
小檗碱噁唑化合物,采用了核磁共振(NMR)、红外光谱(IR)、质谱(MS)和高分辨率质谱(HRMS)等技术。对所有新制备的化合物进行了抗菌活性筛选。
生物活性实验表明,大多数
小檗碱噁唑化合物表现出良好的抗菌活性。特别是化合物7a在抑制变形杆菌和抗念珠菌微球菌方面显示出显著效果,其活性与参考药物相当甚至更好。化合物7a与人
血清白蛋白(H
SA)的结合行为表明,疏
水作用和氢键在化合物7a与H
SA的结合中起着重要作用。分子对接实验表明,化合物7a对H
SA具有适度亲和力,而且理论计算结果与实验结果一致。